EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis

Jianbo Qing iD, Jiejun Wen, Xiao Wang, Yiting Zhao iD, Xiaoyun Shen iD, Xinyu Huang, Ruipeng Wei, Xinni Wang iD, Minchao Kang iD, Linnan Bai, Lei Zhou iD, Xiaodong Wang und 2 weitere

Journal of the American Society of Nephrology · 2026-03 · 37 (3) · 504-521

DOI: 10.1681/asn.0000000856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 22.09.2025. Verfasst von Jianbo Qing und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Programme, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Upregulation of Bmpr2 was identified as a central cause of glomerular endothelial cell activation and injury in lupus nephritis. Glomerular endothelial cells with elevated Bmpr2 expression promoted inflammatory differentiation of macrophages. C5a mediated the increase in Bmpr2 expression in glomerular endothelial cells.

Background

Lupus nephritis, a severe complication of SLE, is closely associated with the abnormal activation of glomerular endothelial cells. Despite its significance, the core mechanisms underlying glomerular endothelial cell activation remain elusive.

Methods

We performed single-nucleus RNA sequencing (snRNA-seq) on kidney tissues from lupus nephritis patients and mouse models to investigate transcriptional alterations in glomerular endothelial cells and validated our findings in two lupus nephritis models: pristane-induced lupus nephritis and murphy roths large/ lpr mice. Genetically modified mice and cultured cells were used to further validate the key discoveries.

Results

Bmpr2 was identified as a critical regulator, showing significant upregulation in glomerular endothelial cells from both lupus nephritis patients and mouse models. Elevated Bmpr2 expression correlated with enhanced glomerular endothelial cell proliferation and migration and increased expression of adhesion molecules (Vcam1, Icam1). BMPR2 activated SMA- and MAD-related proteins-dependent pathways, leading to the upregulation of downstream targets ID1 and ID3, thereby promoting glomerular endothelial cell hyperactivation. Bmpr2 overexpression amplified glomerular endothelial cell proliferation and migration, whereas inhibition of inhibitor of DNA binding signaling by 4-[6-[4-[2-(4-Morpholinyl)ethoxy]phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline (DMH2) or endothelial-specific Bmpr2 knockout attenuated these effects. Moreover, targeting BMPR2 signaling reduced the infiltration of CD86 + macrophages into lupus nephritis kidneys. Coculture experiments confirmed that Bmpr2 -activated glomerular endothelial cells promoted macrophage differentiation into an inflammatory phenotype. Complement component C5a was identified as a critical upstream inducer of Bmpr2 in glomerular endothelial cells, and inhibition of C5a signaling with the C5aR1 antagonist PMX-53 effectively suppressed Bmpr2 upregulation.

Conclusions

These findings highlight BMPR2 as a key regulator of glomerular endothelial cell injury and macrophage-mediated inflammation in lupus nephritis. Targeting BMPR2 or its upstream activators, such as C5a, effectively treated and improved lupus nephritis.

Schlagwörter

Stichwörter der Autor:innen

biomarkersglomerular endothelial cellsglomerulusimmunologylupus nephritismacrophagessystemic lupus erythematosus

Autor:innen und Institutionen

  • Department of Nephrology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Children's Medical Center, Pediatric Translationa Medcine Institute, Shanghai, China.
  • Core Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Rheumatology and Immunology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Jianbo Qing, Yiting Zhao, Xiaoyun Shen, Xinni Wang, Minchao Kang, Lei Zhou, Junnan Wu

Förderung

  • Key Programme
  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Qing, J., Wen, J., Wang, X., Zhao, Y., Shen, X., Huang, X., Wei, R., Wang, X., Kang, M., Bai, L., Zhou, L., Wang, X., Tong, Q., & Wu, J. (2026). Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis. Journal of the American Society of Nephrology, 37(3), 504-521. https://doi.org/10.1681/asn.0000000856

Vancouver

Qing J, Wen J, Wang X, Zhao Y, Shen X, Huang X, et al. Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis. Journal of the American Society of Nephrology. 2026;37(3):504-521. doi:10.1681/asn.0000000856

BibTeX
@article{Qing2026,
  author = {Qing, Jianbo and Wen, Jiejun and Wang, Xiao and Zhao, Yiting and Shen, Xiaoyun and Huang, Xinyu and Wei, Ruipeng and Wang, Xinni and Kang, Minchao and Bai, Linnan and Zhou, Lei and Wang, Xiaodong and Tong, Qiang and Wu, Junnan},
  title = {Bmpr2 Drives Aberrant Activation and Injury of Glomerular Endothelial Cells in Lupus Nephritis},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {3},
  pages = {504--521},
  doi = {10.1681/asn.0000000856}
}
Kostenlos starten →